Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Adam Gilbert, PhD
EXECUTIVE DIRECTOR AND EXTERNAL ACCELERATOR LEAD, PFIZER
From Serendipity to Rational Design, Redefining the Rules of Molecular Glue Discovery
Placeholder Photo
Ryan Gill, PhD
CEO, CO-FOUNDER, ARTISAN BIO
Artisan Bio
Louisville, Colorado, United States
Christoph Glaetzer
GLOBAL HEAD OF MARKET ACCESS, JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
Bringing Value Assessments into the 21st Century: A Multi-Stakeholder Perspective
New York City, New York, United States
Jacob Glanville, PhD
FOUNDER & CEO, CENTIVAX
Centivax
South San Francisco, California, United States
Placeholder Photo
Martin Gleave, MD
CMO, SUSTAINED THERAPEUTICS
Sustained Therapeutics
Bothell, Washington, United States
Matt Gline
CHIEF EXECUTIVE OFFICER, ROIVANT SCIENCES
Biopharma Dealmaking in Uncertain Times
Gregory Glover, MD,JD
PRINCIPAL, PHARMACEUTICAL LAW GROUP PC
Driving the Rare Disease Innovation Pipeline to Bring New Products to Market
Washington, United States
Richard Godfrey
BUSINESS DEVELOPMENT LICENSING, PARTNERING AND COLLABORATIONS, QBIOTICS
QBiotics Group
Zelanna Goldberg
CHIEF MEDICAL OFFICER, REPLICATE BIOSCIENCE
Emerging RNA Therapy Platforms: The Next Generation Genetic Medicines
San Diego, California, United States
Manijeh Goldberg, PhD
PRESIDENT & CEO, PRIVO TECHNOLOGIES INC.
Privo Technologies Inc,
Peabody, Massachusetts, United States